Search
departments › ... › support
… … INSTINCT offers several events throughout the year to get you started and motivated though the process of … track of developments and throughout the IP process and commercialization efforts with BCM Ventures. Contact us at … and will help your foster relationships with investors and companies that help you advance your invention towards …
news › dr-john-p-williams-class-of-1997
… professional career to advancing quality cancer care in his community. On a national level, he advises the President of … enhance the team approach of breast specialists working together to treat this disease. In 2009, The UVA Community … allowed us to treat our patients, and it has helped women get better cancer care. But eventually I realized the …
news › disease-causing-genetic-changes-chromosome-17
… two groups. One group includes individuals that have in common the same alterations in the same area of DNA. We call … pattern of variation within the non-recurrent group is more complex than that of the recurrent group,” Beck said. “We … with mutations within these regions, while 13 out of 26 patients in the non-recurrent group had mutations and …
research › ... › publications
… Chem. 2012 Feb 3;287(6):4014-22. doi: 10.1074/jbc.M111.312264. Epub 2011 Nov 10. PMID:22074915 Hou S, Horrigan FT, Xu R, Heinemann SH, Hoshi T. Comparative effects of H+ and Ca2+ on large-conductance … doi: 10.1074/jbc.M109.027789. Epub 2009 Jun 26. PMID:19561088 Horrigan FT, Hoshi T. Integration of an …
research › ... › publications
… States: A Qualitative Investigation. Nutrients. 2021 Nov 26;13(12). doi: 10.3390/nu13124267. PubMed PMID: 34959818; PubMed Central PMCID: … of Black and Hispanic Children Living in Under-Resourced Communities on Meal Preparation and Grocery Shopping …
news › a-promising-approach-to-develop-a-birth-control-pill-for-men
… The world’s population has increased by more than 2.6-fold in the last 60 years. The growing trend continues – … testis size. “STK33 is therefore considered a viable target with minimal safety concerns for contraception in men,” … Chemistry Technology (DEC-Tec) to screen our multi-billion compound collection to discover potent STK33 inhibitors,” …
research › ... › publications
… Chowdhury S, Korp JD, O’Malley BW, Lonard DM, Wang J. Lead Compound Development of SRC-3 Inhibitors with Improved … 3. Paudel RR, Lu D, Roy Chowdhury S, Monroy EY, Wang J. Targeted Protein Degradation via Lysosomes. Biochemistry. … Chem Soc Rev. England; 2022 Nov 14;51(22):9243–9261. PMCID: PMC9669245 5. Yu X, Guo WH, Lin H, Cheng R, …
news › bristol-myers-squibb-foundation-texas-childrens-global-hope-baylor-college-of-medicine-global-health-launch-program-to-combat-sickle-cell-disease-in-sub-saharan-africa
… a drug that reduces sickling of blood cells to prevent complications of SCD. The program also will train local … centers in eight countries. They have treated more than 26,000 children with cancer, SCD and blood disorders to … of Health to address sickle cell disease in Africa, together with colleagues and partners in Africa we have …
news › fda-ind-clearance-for-stxbp1-developmental-and-epileptic-encephalopathy-therapy
… gene therapy that crosses the blood-brain-barrier and detargets the liver to enter human clinical trials. STXBP1-DEE is estimated to affect up to one in 26,000 births globally, which is approximately 5,000 … that CAP-002 may have potential to meaningfully improve outcomes in patients with this disease.” Gene therapy for …
academic-centers › ... › protocols-workflow
… antibody (15 min) TBST (5 min) SABC (Streptavidin-Biotin Complex) TBST (5 min) TSA reagent (15 min) TBST (5 min) … by #1 total protein slide while antibody-labeled slides #26-#49 and #51-75 are normalized by slide #50 total protein …
